Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism

NLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin-associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowledge about the long-term disease behavior is limited. Herein we assembled t...

Descripción completa

Detalles Bibliográficos
Autores: Bonet, Núria, Pesqué, David, Giménez Arnau, Anna Maria, Laayouni, Hafid, 1968-, Fornas Carreño, Oscar, Aróstegui Gorospe, Juan Ignacio
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/71790
Acceso en línea:http://hdl.handle.net/10230/71790
http://dx.doi.org/10.1007/s10875-025-01922-x
Access Level:acceso abierto
Palabra clave:Autoinflammatory diseases
Inflammasome
NLRP3 gene
Mosaicism
Interleukin-1
Interleukin-1 inhibitors
id ES_b0b520dff4dc4e9d0f0af9471cdf73a1
oai_identifier_str oai:recercat.cat:10230/71790
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
title Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
spellingShingle Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
Bonet, Núria
Autoinflammatory diseases
Inflammasome
NLRP3 gene
Mosaicism
Interleukin-1
Interleukin-1 inhibitors
title_short Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
title_full Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
title_fullStr Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
title_full_unstemmed Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
title_sort Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism
dc.creator.none.fl_str_mv Bonet, Núria
Pesqué, David
Giménez Arnau, Anna Maria
Laayouni, Hafid, 1968-
Fornas Carreño, Oscar
Aróstegui Gorospe, Juan Ignacio
author Bonet, Núria
author_facet Bonet, Núria
Pesqué, David
Giménez Arnau, Anna Maria
Laayouni, Hafid, 1968-
Fornas Carreño, Oscar
Aróstegui Gorospe, Juan Ignacio
author_role author
author2 Pesqué, David
Giménez Arnau, Anna Maria
Laayouni, Hafid, 1968-
Fornas Carreño, Oscar
Aróstegui Gorospe, Juan Ignacio
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Autoinflammatory diseases
Inflammasome
NLRP3 gene
Mosaicism
Interleukin-1
Interleukin-1 inhibitors
topic Autoinflammatory diseases
Inflammasome
NLRP3 gene
Mosaicism
Interleukin-1
Interleukin-1 inhibitors
description NLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin-associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowledge about the long-term disease behavior is limited. Herein we assembled the largest cohort of individuals with NLRP3 mosaicism reported to date to obtain additional evidence that strengthens the understanding of this disease. The novel genetic data were obtained by using Sanger and next-generation sequencing methods, whereas in vitro analyses determined the functional consequences of detected variants. A total of seventeen individuals with NLRP3 mosaicism were enrolled, with 16/17 experiencing different CAPS phenotypes. An overrepresentation of late-onset forms was detected (37.5%). Overall, clinical manifestations, analytical results, and outcomes of treatments were markedly similar to those detected in patients with germline variants. A large mutational diversity was identified, with 16 different variants among 17 individuals. Two main patterns of mosaicism (extended vs. myeloid-restricted) were detected, with the last one overrepresented in the late-onset group. The evaluation of mosaicism over time identified three different patterns, being the group with stable mosaicism the largest one. Collected evidence supports the marked similarities among patients carrying somatic or germline NLRP3 variants. The overrepresentation of NLRP3 mosaicism in late-onset forms should be considered in patients with inflammatory manifestations starting in adulthood. Analysis of mosaicism at the biological level confirms the two known patterns of corporal distribution and reveals that mosaicism remains stable over time in most patients, but it may also vary during the course of the disease.
publishDate 2025
dc.date.none.fl_str_mv 2025
2025
2025
2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/71790
http://dx.doi.org/10.1007/s10875-025-01922-x
http://hdl.handle.net/10230/71790
url http://hdl.handle.net/10230/71790
http://dx.doi.org/10.1007/s10875-025-01922-x
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Journal of Clinical Immunology. 2025;45(1):134
info:eu-repo/grantAgreement/ES/3PE/PID2021-125106OB-C31
info:eu-repo/grantAgreement/ES/2PE/PID2020-116709RB-I00
info:eu-repo/grantAgreement/ES/3PE/CNS2022-135101
info:eu-repo/grantAgreement/ES/3PE/PID2023-147531OB-I00
info:eu-repo/grantAgreement/ES/3PE/PID2021-125106OB-C32
info:eu-repo/grantAgreement/ES/3PE/RED2022-134511-T
info:eu-repo/grantAgreement/ES/3PE/PID2021-125106OB-C33
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869416849502896128
spelling Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicismBonet, NúriaPesqué, DavidGiménez Arnau, Anna MariaLaayouni, Hafid, 1968-Fornas Carreño, OscarAróstegui Gorospe, Juan IgnacioAutoinflammatory diseasesInflammasomeNLRP3 geneMosaicismInterleukin-1Interleukin-1 inhibitorsNLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin-associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowledge about the long-term disease behavior is limited. Herein we assembled the largest cohort of individuals with NLRP3 mosaicism reported to date to obtain additional evidence that strengthens the understanding of this disease. The novel genetic data were obtained by using Sanger and next-generation sequencing methods, whereas in vitro analyses determined the functional consequences of detected variants. A total of seventeen individuals with NLRP3 mosaicism were enrolled, with 16/17 experiencing different CAPS phenotypes. An overrepresentation of late-onset forms was detected (37.5%). Overall, clinical manifestations, analytical results, and outcomes of treatments were markedly similar to those detected in patients with germline variants. A large mutational diversity was identified, with 16 different variants among 17 individuals. Two main patterns of mosaicism (extended vs. myeloid-restricted) were detected, with the last one overrepresented in the late-onset group. The evaluation of mosaicism over time identified three different patterns, being the group with stable mosaicism the largest one. Collected evidence supports the marked similarities among patients carrying somatic or germline NLRP3 variants. The overrepresentation of NLRP3 mosaicism in late-onset forms should be considered in patients with inflammatory manifestations starting in adulthood. Analysis of mosaicism at the biological level confirms the two known patterns of corporal distribution and reveals that mosaicism remains stable over time in most patients, but it may also vary during the course of the disease.This work has been partially funded by: • PID2021-125106OB-C31 (JIA), PID2020-116709RB-I00 (PP), CNS2022-135101 (PP), PID2023-147531OB-I00 (PP), PID2021-125106OB-C32 (FC), RED2022-134511-T (PP, JIA) and PID2021-125106OB-C33 (OF) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | https://doi.org/10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE | European Union «Next Generation EU/PRTR». • AC21_2/00042 (JIA) and IFI22/00031 (JG-V) grants from the Instituto de Salud Carlos III co-funded by Unión Europea Next Generation EU | Mecanismo para la Recuperación y la Resiliencia (MRR) | Plan de Recuperación, Transformación y Resiliencia (PRTR). • 2021SGR01093 | Agència de Gestió d’Ajuts Universitaris i de Recerca | Generalitat de Catalunya (FC). • 21897/PI/22 (PP) and 21214/FPI/19 (LH-N) | Fundación Séneca, Región de Murcia, Spain.Springer2025202520252025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/71790http://dx.doi.org/10.1007/s10875-025-01922-xhttp://hdl.handle.net/10230/71790reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésJournal of Clinical Immunology. 2025;45(1):134info:eu-repo/grantAgreement/ES/3PE/PID2021-125106OB-C31info:eu-repo/grantAgreement/ES/2PE/PID2020-116709RB-I00info:eu-repo/grantAgreement/ES/3PE/CNS2022-135101info:eu-repo/grantAgreement/ES/3PE/PID2023-147531OB-I00info:eu-repo/grantAgreement/ES/3PE/PID2021-125106OB-C32info:eu-repo/grantAgreement/ES/3PE/RED2022-134511-Tinfo:eu-repo/grantAgreement/ES/3PE/PID2021-125106OB-C33© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:10230/717902026-05-29T05:05:01Z
score 15.811543

Similares en LA Referencia